SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2024-11-07 01:33
Tx date 2024-11-04 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+375,000 vol 		1,591,956
Filed 2024-11-04 17:36
Tx date 2024-10-31 		$HEM
Hemostemix Inc. 		Hershman, Ronnie Allen Hershman
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$28,000
+280,000 vol
$0.10 each 		280,000
Filed 2024-11-04 17:30
Tx date 2020-02-10 		$HEM
Hemostemix Inc. 		Hershman, Ronnie Allen Hershman
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2024-11-04 17:00
Tx date 2024-10-31 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$28,000
+280,000 vol
$0.10 each 		742,330
Filed 2024-11-04 12:24
Tx date 2024-10-31 		$HEM
Hemostemix Inc. 		Wu, Christina Yuen-Ling
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$4,000
+40,000 vol
$0.10 each 		203,000
Filed 2024-11-04 11:01
Tx date 2024-10-31 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$122,500
+1,225,000 vol
$0.10 each 		4,433,928
Filed 2024-10-31 16:00
Tx date 2024-10-31 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately
+3,009,491 vol 		3,670,891
Filed 2024-10-31 15:56
Tx date 2024-10-31 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$150,474
+3,009,491 vol
$0.05 each 		3,009,491
Filed 2024-10-28 12:39
Tx date 2024-10-28 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Loran and Tanya Swanberg JT (Indirect Ownership)
Warrants
53 - Grant of warrants 		$48,000
+400,000 vol
$0.12 each 		1,025,000
Filed 2024-10-28 12:38
Tx date 2024-10-28 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Loran and Tanya Swanberg JT (Indirect Ownership)
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$20,000
+400,000 vol
$0.05 each 		2,408,500
Filed 2024-10-18 18:39
Tx date 2024-10-18 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-2,106.975
-28,093 vol
$0.075 each 		0
Filed 2024-10-18 18:38
Tx date 2024-10-17 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-11,900
-170,000 vol
$0.07 each 		28,093
Filed 2024-10-18 18:35
Tx date 2024-10-16 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-3,900
-60,000 vol
$0.065 each 		198,093
Filed 2024-10-09 10:48
Tx date 2024-10-08 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-4,842.50
-74,500 vol
$0.065 each 		258,093
Filed 2024-10-08 21:46
Tx date 2024-10-08 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-21,612.50
-332,500 vol
$0.065 each
Filed 2024-10-08 21:46
Tx date 2024-10-08 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-21,612.50
-332,500 vol
$0.065 each 		93
Filed 2024-10-08 21:43
Tx date 2024-10-07 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-21,350
-305,000 vol
$0.07 each 		332,593
Filed 2024-10-08 21:40
Tx date 2024-10-07 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-33,250
-475,000 vol
$0.07 each 		637,593
Filed 2024-10-08 21:38
Tx date 2024-10-04 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-21,000
-300,000 vol
$0.07 each 		1,112,593
Filed 2024-10-08 21:37
Tx date 2024-10-04 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-28,000
-400,000 vol
$0.07 each 		1,412,593
Filed 2024-08-23 11:20
Tx date 2024-08-21 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$80.00
+2,000 vol
$0.04 each 		1,812,593
Filed 2024-06-25 13:01
Tx date 2024-06-25 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$400.00
+10,000 vol
$0.04 each 		1,810,593
Filed 2024-05-02 08:55
Tx date 2024-05-01 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$1,600
+40,000 vol
$0.04 each 		1,800,593
Filed 2024-03-06 13:48
Tx date 2024-03-04 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$12,600
+180,000 vol
$0.07 each 		180,000
Filed 2024-03-06 13:46
Tx date 2024-03-04 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-12,600
-180,000 vol
$0.07 each 		462,330
Filed 2024-03-05 17:39
Tx date 2024-03-05 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$49,000
+700,000 vol
$0.07 each 		3,208,928
Filed 2024-03-05 16:57
Tx date 2024-03-05 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$17,500
+250,000 vol
$0.07 each 		1,216,956
Filed 2024-01-04 12:01
Tx date 2023-12-29 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$12,600
+180,000 vol
$0.07 each 		642,330
Filed 2024-01-03 17:48
Tx date 2023-12-29 		$HEM
Hemostemix Inc. 		Wu, Christina Yuen-Ling
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$1,750
+25,000 vol
$0.07 each 		163,000
Filed 2024-01-03 13:46
Tx date 2023-12-29 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+250,000 vol 		966,956
Filed 2024-01-02 21:49
Tx date 2023-12-29 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$49,000
+700,000 vol
$0.07 each 		2,508,928
Filed 2023-12-20 18:01
Tx date 2023-12-18 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: LTUS Ltd. (Indirect Ownership)
Warrants
55 - Expiration of warrants 		$-139,119.75
-252,945 vol
$0.55 each 		0
Filed 2023-12-20 18:00
Tx date 2023-12-18 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Landsman Properties Ltd, (Indirect Ownership)
Warrants
55 - Expiration of warrants 		$-209,687.50
-381,250 vol
$0.55 each 		0
Filed 2023-12-20 17:18
Tx date 2023-12-20 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants
-1,903,625 vol 		661,400
Filed 2023-12-14 09:32
Tx date 2023-12-14 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$1,400
+20,000 vol
$0.07 each 		1,760,593
Filed 2023-12-07 12:48
Tx date 2023-12-05 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$910.00
+13,000 vol
$0.07 each 		1,740,593
Filed 2023-11-08 10:17
Tx date 2023-11-08 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$4,800
+60,000 vol
$0.08 each 		1,727,593
Filed 2023-11-07 09:49
Tx date 2023-11-07 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$1,750
+25,000 vol
$0.07 each 		1,667,593
Filed 2023-11-02 11:55
Tx date 2023-11-02 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$6,500
+100,000 vol
$0.065 each 		1,642,593
Filed 2023-11-01 13:04
Tx date 2023-11-01 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$3,500
+50,000 vol
$0.07 each 		1,542,593
Filed 2023-10-26 15:51
Tx date 2023-10-24 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Loran and Tanya Swanberg JT (Indirect Ownership)
Common Shares
11 - Acquisition or disposition carried out privately
+758,500 vol 		2,008,500
Filed 2023-10-26 15:50
Tx date 2023-10-24 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
-758,500 vol 		0
Filed 2023-10-26 15:48
Tx date 2021-01-04 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Loran and Tanya Swanberg JT (Indirect Ownership)
Common Shares
37 - Stock split or consolidation
-12,160,000 vol
Filed 2023-10-26 15:47
Tx date 2020-04-08 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Loran and Tanya Swanberg JT (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2023-09-13 18:43
Tx date 2021-01-04 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Loran and Tanya Swanberg JT (Indirect Ownership)
Common Shares
37 - Stock split or consolidation
-12,160,000 vol
Filed 2020-04-21 11:44
Tx date 2020-04-08 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Loran and Tanya Swanberg JT (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2023-09-13 18:43
Tx date 2021-01-04 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Loran and Tanya Swanberg JT (Indirect Ownership)
Common Shares
37 - Stock split or consolidation
-12,160,000 vol 		640,000
Filed 2023-08-04 15:55
Tx date 2023-08-03 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
97 - Other
+29,234 vol 		1,492,593
Filed 2023-06-28 19:56
Tx date 2023-06-27 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Loran and Tanya Swanberg JT (Indirect Ownership)
Warrants
53 - Grant of warrants 		$156,250
+625,000 vol
$0.25 each 		625,000
Filed 2023-06-28 19:54
Tx date 2023-06-27 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Loran and Tanya Swanberg JT (Indirect Ownership)
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$150,000
+1,250,000 vol
$0.12 each 		14,050,000
Filed 2023-05-04 08:57
Tx date 2023-05-03 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$600.00
+4,000 vol
$0.15 each 		1,463,359
Filed 2023-04-17 13:37
Tx date 2022-03-03 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Common Shares
46 - Compensation for services 		$84,113
+442,700 vol
$0.19 each 		4,688,127
Filed 2023-04-17 13:33
Tx date 2023-03-29 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Common Shares
46 - Compensation for services 		$126,011
+672,420 vol
$0.1874 each
Filed 2023-04-17 13:33
Tx date 2023-03-29 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Common Shares
46 - Compensation for services 		$153,408
+639,203 vol
$0.24 each
Filed 2023-03-30 15:00
Tx date 2023-03-29 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Common Shares
46 - Compensation for services 		$126,011
+672,420 vol
$0.1874 each
Filed 2023-03-30 14:57
Tx date 2023-03-29 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Common Shares
46 - Compensation for services 		$153,408
+639,203 vol
$0.24 each
Filed 2022-03-06 15:05
Tx date 2022-03-03 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Common Shares
46 - Compensation for services 		$84,804
+446,339 vol
$0.19 each
Filed 2023-04-14 19:18
Tx date 2020-12-31 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Loran and Tanya Swanberg JT (Indirect Ownership)
Warrants
37 - Stock split or consolidation
-11,875,000 vol 		625,000
Filed 2023-04-14 16:45
Tx date 2023-04-14 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$640.00
+4,000 vol
$0.16 each 		1,459,359
Filed 2023-04-06 16:17
Tx date 2023-04-06 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$4,425
+30,000 vol
$0.1475 each 		1,455,359
Filed 2023-04-03 22:34
Tx date 2023-04-03 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$9,672
+65,000 vol
$0.1488 each 		1,425,359
Filed 2023-03-30 15:36
Tx date 2023-03-30 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$4,500
+30,000 vol
$0.15 each 		1,360,359
Filed 2023-03-30 15:31
Tx date 2023-03-29 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
46 - Compensation for services 		$5,466
+29,234 vol
$0.187 each 		1,330,359
Filed 2023-03-30 15:00
Tx date 2023-03-29 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Common Shares
46 - Compensation for services 		$126,011
+672,420 vol
$0.1874 each 		7,315,012
Filed 2023-03-30 14:57
Tx date 2023-03-29 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Common Shares
46 - Compensation for services 		$153,408
+639,203 vol
$0.24 each 		6,642,592
Filed 2023-03-24 16:55
Tx date 2023-03-24 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants
-180,000 vol 		2,565,025
Filed 2023-03-14 18:30
Tx date 2023-03-14 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Warrants
55 - Expiration of warrants
-10,600,000 vol 		13,142,200
Filed 2023-03-07 09:25
Tx date 2023-03-05 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Tanya Swanberg (Indirect Ownership)
Warrants
55 - Expiration of warrants
-95,000 vol 		0
Filed 2023-03-07 09:25
Tx date 2023-03-05 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Landsman Properties Ltd, (Indirect Ownership)
Warrants
55 - Expiration of warrants
-750,000 vol 		381,250
Filed 2023-03-07 09:24
Tx date 2023-03-05 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Loran and Tanya Swanberg JT (Indirect Ownership)
Warrants
55 - Expiration of warrants
-625,000 vol 		11,875,000
Filed 2023-03-07 09:23
Tx date 2021-05-12 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately
+500,000 vol
Filed 2023-03-07 09:22
Tx date 2023-03-05 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: LTUS Ltd. (Indirect Ownership)
Warrants
55 - Expiration of warrants
-625,000 vol 		252,945
Filed 2023-03-07 09:20
Tx date 2023-03-05 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants
-625,000 vol 		0
Filed 2021-05-15 22:27
Tx date 2021-05-12 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately
+500,000 vol
Filed 2023-02-14 19:00
Tx date 2023-02-13 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: Summerhill Inv Corp (Control or Direction)
Warrants
55 - Expiration of warrants
-150,000 vol 		0
Filed 2023-02-14 18:50
Tx date 2023-02-13 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Common Shares
45 - Compensation for property 		$126,011
+672,420 vol
$0.1874 each 		6,003,389
Filed 2023-02-14 18:48
Tx date 2023-02-13 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Common Shares
45 - Compensation for property 		$153,408
+639,203 vol
$0.24 each 		5,330,969
Filed 2023-02-07 09:37
Tx date 2023-02-07 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$4,600
+20,000 vol
$0.23 each 		1,301,125
Filed 2023-02-07 09:37
Tx date 2023-02-06 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$440.00
+2,000 vol
$0.22 each 		1,281,125
Filed 2023-01-30 14:20
Tx date 2023-01-30 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$4,400
+20,000 vol
$0.22 each 		1,279,125
Filed 2022-12-06 11:32
Tx date 2022-12-05 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$2,800
+20,000 vol
$0.14 each 		1,259,125
Filed 2022-12-06 11:31
Tx date 2022-12-05 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$2,900
+20,000 vol
$0.145 each 		1,239,125
Filed 2022-10-25 10:53
Tx date 2022-10-25 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$4,200
+30,000 vol
$0.14 each 		1,219,125
Filed 2022-10-25 10:52
Tx date 2022-10-24 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$3,000
+20,000 vol
$0.15 each 		1,189,125
Filed 2022-07-14 17:25
Tx date 2022-07-14 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Warrants
16 - Acquisition or disposition under a prospectus exemption 		$2,628,440
+13,142,200 vol
$0.20 each 		23,742,200
Filed 2022-07-14 17:22
Tx date 2022-07-14 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Convertible Debentures
16 - Acquisition or disposition under a prospectus exemption 		$
+$2,300 vol
$1,000 each 		$4,800
Filed 2022-05-09 09:55
Tx date 2022-05-04 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$6,000
+20,000 vol
$0.30 each 		1,169,125
Filed 2022-04-26 22:33
Tx date 2022-04-26 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+161,956 vol 		716,956
Filed 2022-04-26 16:30
Tx date 2022-02-28 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+45,830 vol 		462,330
Filed 2022-04-22 11:49
Tx date 2022-04-18 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-93,210
-300,000 vol
$0.3107 each 		1,149,125
Filed 2022-04-22 11:41
Tx date 2022-04-22 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately 		$114,280
+571,400 vol
$0.20 each 		2,745,025
Filed 2022-04-22 11:36
Tx date 2022-04-22 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Convertible Debentures
11 - Acquisition or disposition carried out privately 		$
+$100 vol
$1,000 each 		$100
Filed 2022-04-22 11:35
Tx date 2019-11-26 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
Filed 2022-03-21 22:05
Tx date 2022-02-28 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$71,489
+420,528 vol
$0.17 each 		1,808,928
Filed 2022-03-01 09:57
Tx date 2022-02-28 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$75,884
+446,381 vol
$0.17 each
Filed 2022-03-06 15:05
Tx date 2022-03-03 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Common Shares
46 - Compensation for services 		$84,804
+446,339 vol
$0.19 each 		4,691,766
Filed 2022-03-06 15:03
Tx date 2022-02-28 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Common Shares
46 - Compensation for services 		$84,804
+605,746 vol
$0.14 each
Filed 2022-03-02 10:44
Tx date 2022-02-28 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Common Shares
46 - Compensation for services 		$84,804
+605,746 vol
$0.14 each
Filed 2022-03-02 10:44
Tx date 2022-02-28 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Common Shares
46 - Compensation for services 		$84,804
+605,746 vol
$0.14 each 		4,851,173
Filed 2022-03-01 09:57
Tx date 2022-02-28 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$75,884
+446,381 vol
$0.17 each 		1,834,781
Filed 2022-02-28 20:36
Tx date 2022-02-28 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately
+700,000 vol 		2,173,625
Filed 2022-02-28 20:31
Tx date 2022-02-28 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$98,000
+700,000 vol
$0.14 each 		1,449,125
Filed 2021-12-03 11:53
Tx date 2021-12-03 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$675.00
+5,000 vol
$0.135 each 		749,125
Filed 2021-12-03 11:52
Tx date 2021-12-03 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$700.00
+5,000 vol
$0.14 each 		744,125
Filed 2021-08-03 23:15
Tx date 2021-08-03 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$4,300
+20,000 vol
$0.215 each 		739,125
Filed 2021-06-17 21:42
Tx date 2021-06-14 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Warrants
16 - Acquisition or disposition under a prospectus exemption 		$3,437,500
+6,250,000 vol
$0.55 each 		10,600,000
Filed 2021-06-17 21:40
Tx date 2021-06-14 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Convertible Debentures
16 - Acquisition or disposition under a prospectus exemption 		$
+$2,500 vol
$1,000 each 		$2,500
Filed 2021-06-17 21:39
Tx date 2020-03-19 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
Filed 2021-06-17 21:25
Tx date 2021-06-14 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$61,620
+237,000 vol
$0.26 each 		4,245,427
Filed 2021-06-17 21:17
Tx date 2021-06-17 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation 		$19,292
+96,464 vol
$0.20 each 		96,464
Filed 2021-06-17 21:16
Tx date 2021-06-17 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation
-19,292,285 vol 		0
Filed 2021-05-17 16:50
Tx date 2021-02-05 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Landsman Properties Ltd, (Indirect Ownership)
Common Shares
37 - Stock split or consolidation
+381,250 vol 		765,000
Filed 2021-05-17 16:47
Tx date 2021-02-05 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Landsman Properties Ltd, (Indirect Ownership)
Common Shares
37 - Stock split or consolidation
-7,625,000 vol 		383,750
Filed 2021-05-17 16:44
Tx date 2021-01-04 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Landsman Properties Ltd, (Indirect Ownership)
Common Shares
37 - Stock split or consolidation
+383,750 vol 		8,008,750
Filed 2021-05-17 16:38
Tx date 2021-01-04 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Landsman Properties Ltd, (Indirect Ownership)
Common Shares
37 - Stock split or consolidation
-7,675,000 vol 		7,625,000
Filed 2021-05-15 20:15
Tx date 2020-12-31 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Landsman Properties Ltd, (Indirect Ownership)
Common Shares
37 - Stock split or consolidation
+765,000 vol
Filed 2021-05-15 20:12
Tx date 2020-12-31 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Landsman Properties Ltd, (Indirect Ownership)
Common Shares
37 - Stock split or consolidation
-15,300,000 vol
Filed 2021-05-16 15:06
Tx date 2021-01-04 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation
+640,000 vol 		640,000
Filed 2021-05-16 15:04
Tx date 2021-01-04 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation
-12,800,000 vol 		0
Filed 2021-05-16 14:59
Tx date 2020-04-08 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		12,800,000
Filed 2021-05-16 12:20
Tx date 2021-02-12 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: LTUS Ltd. (Indirect Ownership)
Common Shares
37 - Stock split or consolidation
+252,945 vol 		977,945
Filed 2021-05-16 12:16
Tx date 2021-02-12 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: LTUS Ltd. (Indirect Ownership)
Common Shares
37 - Stock split or consolidation
-5,058,904 vol 		725,000
Filed 2021-05-16 11:57
Tx date 2021-01-11 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: LTUS Ltd. (Indirect Ownership)
Warrants
37 - Stock split or consolidation
+252,945 vol 		877,945
Filed 2021-05-16 11:51
Tx date 2021-01-11 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: LTUS Ltd. (Indirect Ownership)
Warrants
37 - Stock split or consolidation
-5,058,904 vol 		625,000
Filed 2021-05-16 11:46
Tx date 2021-01-04 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: LTUS Ltd. (Indirect Ownership)
Common Shares
37 - Stock split or consolidation
+725,000 vol 		5,783,904
Filed 2021-05-16 11:42
Tx date 2021-01-04 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: LTUS Ltd. (Indirect Ownership)
Common Shares
37 - Stock split or consolidation
-14,500,000 vol 		5,058,904
Filed 2021-05-16 11:38
Tx date 2020-12-31 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: LTUS Ltd. (Indirect Ownership)
Warrants
37 - Stock split or consolidation
+625,000 vol 		5,683,904
Filed 2021-05-16 11:30
Tx date 2020-12-31 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: LTUS Ltd. (Indirect Ownership)
Warrants
37 - Stock split or consolidation
-12,500,000 vol 		5,058,904
Filed 2021-04-23 17:46
Tx date 2020-04-08 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-15 22:27
Tx date 2021-05-12 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately
+500,000 vol 		1,125,000
Filed 2021-05-15 22:17
Tx date 2020-12-31 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Direct Ownership
Warrants
37 - Stock split or consolidation
+625,000 vol 		625,000
Filed 2021-05-15 22:13
Tx date 2020-12-31 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Direct Ownership
Warrants
37 - Stock split or consolidation
-12,500,000 vol 		0
Filed 2021-05-15 21:00
Tx date 2021-01-04 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Landsman Properties Ltd, (Indirect Ownership)
Warrants
37 - Stock split or consolidation
+381,250 vol 		1,131,250
Filed 2021-05-15 20:55
Tx date 2021-01-04 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Landsman Properties Ltd, (Indirect Ownership)
Warrants
37 - Stock split or consolidation
-7,625,000 vol 		750,000
Filed 2021-05-15 20:30
Tx date 2020-12-31 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Landsman Properties Ltd, (Indirect Ownership)
Warrants
37 - Stock split or consolidation
+750,000 vol 		8,375,000
Filed 2021-05-15 20:24
Tx date 2020-12-31 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Landsman Properties Ltd, (Indirect Ownership)
Warrants
37 - Stock split or consolidation
-15,000,000 vol 		7,625,000
Filed 2021-05-15 20:15
Tx date 2020-12-31 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Landsman Properties Ltd, (Indirect Ownership)
Common Shares
37 - Stock split or consolidation
+765,000 vol 		765,000
Filed 2021-05-15 20:12
Tx date 2020-12-31 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Landsman Properties Ltd, (Indirect Ownership)
Common Shares
37 - Stock split or consolidation
-15,300,000 vol 		0
Filed 2021-05-15 17:11
Tx date 2021-01-04 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Tanya Swanberg (Indirect Ownership)
Common Shares
37 - Stock split or consolidation
+95,000 vol 		95,000
Filed 2021-05-15 17:04
Tx date 2021-01-04 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Tanya Swanberg (Indirect Ownership)
Common Shares
37 - Stock split or consolidation
-1,900,000 vol 		0
Filed 2021-05-15 16:53
Tx date 2020-12-31 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Tanya Swanberg (Indirect Ownership)
Warrants
37 - Stock split or consolidation
+95,000 vol 		95,000
Filed 2021-05-15 16:37
Tx date 2020-12-31 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Tanya Swanberg (Indirect Ownership)
Warrants
37 - Stock split or consolidation
-1,900,000 vol 		0
Filed 2021-05-15 10:22
Tx date 2021-05-10 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately
+50,000 vol 		1,473,625
Filed 2021-05-15 10:19
Tx date 2021-05-10 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$17,500
+50,000 vol
$0.35 each 		719,125
Filed 2021-05-15 09:50
Tx date 2021-05-10 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$17,500
+50,000 vol
$0.35 each 		719,125
Filed 2021-05-15 09:50
Tx date 2021-05-10 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$17,500
+50,000 vol
$0.35 each
Filed 2021-05-15 09:49
Tx date 2021-05-10 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-13,160
-47,000 vol
$0.28 each 		669,125
Filed 2021-05-14 19:48
Tx date 2020-04-08 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report 		12,500,000
Filed 2021-05-12 17:18
Tx date 2021-05-12 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$175,000
+500,000 vol
$0.35 each 		758,500
Filed 2021-04-27 22:10
Tx date 2021-04-26 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-875.00
-2,500 vol
$0.35 each 		258,500
Filed 2021-04-23 17:57
Tx date 2021-04-23 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-74,025
-211,500 vol
$0.35 each 		261,000
Filed 2021-04-23 17:54
Tx date 2021-04-22 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-17,325
-49,500 vol
$0.35 each 		472,500
Filed 2021-04-23 17:51
Tx date 2021-04-21 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-41,300
-118,000 vol
$0.35 each 		522,000
Filed 2021-04-23 17:46
Tx date 2020-04-08 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		640,000
Filed 2021-03-23 23:31
Tx date 2021-03-22 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
-172,500 vol 		716,125
Filed 2021-03-23 23:24
Tx date 2021-03-22 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+172,500 vol
Filed 2021-03-23 14:14
Tx date 2021-03-23 		$HEM
Hemostemix Inc. 		Leimgruber, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report 		100,000
Filed 2021-03-23 14:13
Tx date 2021-03-23 		$HEM
Hemostemix Inc. 		Leimgruber, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		416,500
Filed 2021-03-23 14:09
Tx date 2021-03-23 		$HEM
Hemostemix Inc. 		Leimgruber, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		129,600
Filed 2021-03-23 14:06
Tx date 2021-03-23 		$HEM
Hemostemix Inc. 		Leimgruber, Pierre
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2021-03-16 02:09
Tx date 2021-03-11 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$49,200
+123,000 vol
$0.40 each 		4,008,427
Filed 2021-01-31 20:42
Tx date 2021-01-28 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$17,400
+30,000 vol
$0.58 each 		3,885,427
Filed 2021-01-11 09:53
Tx date 2021-01-08 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$7,650
+15,000 vol
$0.51 each 		888,625
Filed 2021-01-05 16:20
Tx date 2020-12-31 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+416,500 vol 		416,500
Filed 2021-01-05 16:12
Tx date 2020-04-08 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-01-05 15:45
Tx date 2020-12-31 		$HEM
Hemostemix Inc. 		Wu, Christina Yuen-Ling
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+138,000 vol 		138,000
Filed 2021-01-05 15:42
Tx date 2020-04-09 		$HEM
Hemostemix Inc. 		Wu, Christina Yuen-Ling
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-01-04 21:18
Tx date 2020-12-31 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+555,000 vol 		555,000
Filed 2021-01-04 21:17
Tx date 2020-03-19 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-01-04 18:18
Tx date 2020-12-31 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+1,388,400 vol 		1,388,400
Filed 2021-01-04 18:15
Tx date 2019-11-26 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-01-04 18:07
Tx date 2020-12-31 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately 		$21,000
+70,000 vol
$0.30 each 		1,423,625
Filed 2021-01-04 18:05
Tx date 2020-12-31 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Warrants
37 - Stock split or consolidation
-25,718,875 vol 		1,353,625
Filed 2021-01-04 17:59
Tx date 2020-12-31 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$21,000
+70,000 vol
$0.30 each 		873,625
Filed 2021-01-04 17:58
Tx date 2020-12-31 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation
-15,268,875 vol 		803,625
Filed 2021-01-04 17:49
Tx date 2020-12-31 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation
+803,625 vol
Filed 2021-01-04 17:09
Tx date 2020-12-31 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation
+803,625 vol
Filed 2021-01-04 16:39
Tx date 2020-12-31 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$21,000
+70,000 vol
$0.30 each
Filed 2021-01-04 16:38
Tx date 2020-12-31 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately 		$21,000
+70,000 vol
$0.30 each
Filed 2021-01-04 12:32
Tx date 2020-12-30 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: Summerhill Inv Corp (Control or Direction)
Warrants
37 - Stock split or consolidation
+150,000 vol 		150,000
Filed 2021-01-04 12:31
Tx date 2020-12-30 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: Summerhill Inv Corp (Control or Direction)
Warrants
37 - Stock split or consolidation
+150,000 vol
Filed 2021-01-04 12:30
Tx date 2020-12-30 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: Summerhill Inv Corp (Control or Direction)
Warrants
37 - Stock split or consolidation
-3,000,000 vol 		0
Filed 2021-01-04 12:29
Tx date 2020-12-30 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Warrants
16 - Acquisition or disposition under a prospectus exemption
+1,500,000 vol 		4,350,000
Filed 2021-01-04 12:27
Tx date 2020-12-30 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Warrants
37 - Stock split or consolidation
+2,850,000 vol 		2,850,000
Filed 2021-01-04 02:25
Tx date 2020-12-30 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: Summerhill Inv Corp (Control or Direction)
Warrants
37 - Stock split or consolidation
+150,000 vol
Filed 2021-01-04 02:25
Tx date 2020-12-30 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: Summerhill Inv Corp (Control or Direction)
Warrants
37 - Stock split or consolidation
+150,000 vol 		150,000
Filed 2021-01-04 02:23
Tx date 2020-12-30 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: Summerhill Inv Corp (Control or Direction)
Warrants
37 - Stock split or consolidation
-3,000,000 vol
Filed 2021-01-04 02:23
Tx date 2020-12-30 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: Summerhill Inv Corp (Control or Direction)
Warrants
37 - Stock split or consolidation
-3,000,000 vol 		0
Filed 2021-01-04 02:22
Tx date 2020-12-30 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Warrants
16 - Acquisition or disposition under a prospectus exemption
+1,500,000 vol
Filed 2021-01-04 02:22
Tx date 2020-12-30 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Warrants
16 - Acquisition or disposition under a prospectus exemption
+1,500,000 vol 		4,350,000
Filed 2021-01-04 02:20
Tx date 2020-12-30 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Warrants
37 - Stock split or consolidation
+2,850,000 vol 		2,850,000
Filed 2021-01-04 02:20
Tx date 2020-12-30 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Warrants
37 - Stock split or consolidation
+2,850,000 vol
Filed 2021-01-04 02:17
Tx date 2020-12-30 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Warrants
37 - Stock split or consolidation
-57,000,000 vol 		0
Filed 2021-01-04 02:14
Tx date 2020-12-30 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Common Shares
11 - Acquisition or disposition carried out privately 		$115,307
+576,537 vol
$0.20 each 		3,855,427
Filed 2021-01-04 02:12
Tx date 2020-12-30 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$450,000
+1,500,000 vol
$0.30 each 		3,278,890
Filed 2021-01-04 02:10
Tx date 2020-12-30 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: Summerhill Inv Corp (Control or Direction)
Common Shares
37 - Stock split or consolidation
+150,000 vol 		150,000
Filed 2021-01-04 02:09
Tx date 2020-12-30 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: Summerhill Inv Corp (Control or Direction)
Common Shares
37 - Stock split or consolidation
-3,000,000 vol 		0
Filed 2021-01-04 02:08
Tx date 2020-12-30 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Common Shares
37 - Stock split or consolidation
+1,778,890 vol 		1,778,890
Filed 2021-01-04 02:07
Tx date 2020-12-30 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Common Shares
37 - Stock split or consolidation
-35,577,800 vol 		0
Filed 2020-12-31 16:47
Tx date 2020-12-31 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately 		$21,000
+70,000 vol
$0.30 each
Filed 2020-12-31 15:40
Tx date 2020-12-31 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$21,000
+70,000 vol
$0.30 each
Filed 2020-12-31 16:47
Tx date 2020-12-31 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately 		$21,000
+70,000 vol
$0.30 each 		27,142,500
Filed 2020-12-31 15:40
Tx date 2020-12-31 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$21,000
+70,000 vol
$0.30 each 		16,142,500
Filed 2020-12-31 15:39
Tx date 2020-12-29 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-66,000
-2,200,000 vol
$0.03 each 		16,072,500
Filed 2020-12-23 19:20
Tx date 2020-04-08 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Landsman Properties Ltd, (Indirect Ownership)
Subscription Rights Subscription Receipts
00 - Opening Balance-Initial SEDI Report
Filed 2020-12-23 19:20
Tx date 2020-12-18 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Landsman Properties Ltd, (Indirect Ownership)
Subscription Rights Subscription Receipts
15 - Acquisition or disposition under a prospectus 		$76,250
+7,625,000 vol
$0.01 each
Filed 2020-12-23 19:15
Tx date 2020-12-18 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: LTUS Ltd. (Indirect Ownership)
Warrants
53 - Grant of warrants
+5,058,904 vol 		17,558,904
Filed 2020-12-23 19:13
Tx date 2020-12-18 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Landsman Properties Ltd, (Indirect Ownership)
Common Shares
11 - Acquisition or disposition carried out privately 		$76,250
+7,625,000 vol
$0.01 each 		15,300,000
Filed 2020-12-23 19:10
Tx date 2020-12-18 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Landsman Properties Ltd, (Indirect Ownership)
Warrants
11 - Acquisition or disposition carried out privately
+7,625,000 vol 		22,625,000
Filed 2020-12-23 19:00
Tx date 2020-04-08 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Landsman Properties Ltd, (Indirect Ownership)
Subscription Rights Subscription Receipts
00 - Opening Balance-Initial SEDI Report
Filed 2020-12-23 18:56
Tx date 2020-12-18 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Landsman Properties Ltd, (Indirect Ownership)
Subscription Rights Subscription Receipts
15 - Acquisition or disposition under a prospectus 		$76,250
+7,625,000 vol
$0.01 each
Filed 2020-12-23 18:56
Tx date 2020-12-18 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Landsman Properties Ltd, (Indirect Ownership)
Subscription Rights Subscription Receipts
15 - Acquisition or disposition under a prospectus 		$76,250
+7,625,000 vol
$0.01 each 		52,125,000
Filed 2020-12-22 00:57
Tx date 2020-12-18 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Landsman Properties Ltd, (Indirect Ownership)
Subscription Rights Subscription Receipts
15 - Acquisition or disposition under a prospectus 		$76,250
+7,625,000 vol
$0.01 each
Filed 2020-12-22 00:57
Tx date 2020-12-18 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Landsman Properties Ltd, (Indirect Ownership)
Subscription Rights Subscription Receipts
15 - Acquisition or disposition under a prospectus 		$76,250
+7,625,000 vol
$0.01 each
Filed 2020-12-22 00:20
Tx date 2020-04-08 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Landsman Properties Ltd, (Indirect Ownership)
Subscription Rights Subscription Receipts
00 - Opening Balance-Initial SEDI Report
Filed 2020-12-20 21:46
Tx date 2020-12-18 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: LTUS Ltd. (Indirect Ownership)
Warrants
53 - Grant of warrants
+5,058,904 vol
Filed 2020-12-22 00:57
Tx date 2020-12-18 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Landsman Properties Ltd, (Indirect Ownership)
Subscription Rights Subscription Receipts
15 - Acquisition or disposition under a prospectus 		$76,250
+7,625,000 vol
$0.01 each 		52,125,000
Filed 2020-12-22 00:20
Tx date 2020-04-08 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Landsman Properties Ltd, (Indirect Ownership)
Subscription Rights Subscription Receipts
00 - Opening Balance-Initial SEDI Report 		44,500,000
Filed 2020-12-20 21:46
Tx date 2020-12-18 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: LTUS Ltd. (Indirect Ownership)
Warrants
53 - Grant of warrants
+5,058,904 vol 		17,558,904
Filed 2020-12-20 21:12
Tx date 2020-12-18 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: LTUS Ltd. (Indirect Ownership)
Common Shares
36 - Conversion or exchange 		$50,589
+5,058,904 vol
$0.01 each 		19,558,904
Filed 2020-12-19 22:43
Tx date 2020-12-18 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$225,778
+22,577,800 vol
$0.01 each 		35,577,800
Filed 2020-12-19 22:41
Tx date 2020-12-14 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-3,750
-250,000 vol
$0.015 each 		13,000,000
Filed 2020-12-19 22:40
Tx date 2020-12-14 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-5,373.75
-358,250 vol
$0.015 each 		13,250,000
Filed 2020-12-19 22:40
Tx date 2020-12-14 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-2,280
-152,000 vol
$0.015 each 		13,608,250
Filed 2020-12-18 17:44
Tx date 2020-12-18 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately
+10,000,000 vol 		27,072,500
Filed 2020-12-18 17:29
Tx date 2020-12-18 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$100,000
+10,000,000 vol
$0.01 each 		18,272,500
Filed 2020-12-18 17:27
Tx date 2020-12-18 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$100,000
+10,000,000 vol
$0.01 each
Filed 2020-12-12 17:09
Tx date 2020-12-11 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-381,915
-25,461,000 vol
$0.015 each 		13,760,250
Filed 2020-12-12 16:55
Tx date 2020-12-10 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-120,697.50
-12,069,750 vol
$0.01 each 		39,221,250
Filed 2020-12-12 16:54
Tx date 2020-12-08 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-3,300
-220,000 vol
$0.015 each 		51,291,000
Filed 2020-12-12 16:53
Tx date 2020-12-08 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-570.00
-57,000 vol
$0.01 each 		51,511,000
Filed 2020-12-12 16:52
Tx date 2020-12-10 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$192,922
+19,292,285 vol
$0.01 each 		19,292,285
Filed 2020-12-12 12:08
Tx date 2020-11-25 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Warrants
11 - Acquisition or disposition carried out privately
+10,000,000 vol 		57,000,000
Filed 2020-12-12 12:06
Tx date 2020-11-25 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Common Shares
11 - Acquisition or disposition carried out privately 		$100,000
+10,000,000 vol
$0.01 each 		57,362,000
Filed 2020-11-25 15:54
Tx date 2020-11-25 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately
+10,000,000 vol
Filed 2020-11-25 15:50
Tx date 2020-11-25 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately
+100,000,000 vol
Filed 2020-11-25 15:47
Tx date 2020-11-25 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$100,000
+10,000,000 vol
$0.01 each
Filed 2020-12-06 21:37
Tx date 2020-12-03 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Landsman Properties Ltd, (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-50,000
-5,000,000 vol
$0.01 each 		7,675,000
Filed 2020-12-06 21:33
Tx date 2020-12-02 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Landsman Properties Ltd, (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-26,250
-2,625,000 vol
$0.01 each 		12,675,000
Filed 2020-12-06 11:38
Tx date 2020-12-05 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$100,000
+10,000,000 vol
$0.01 each
Filed 2020-12-06 11:30
Tx date 2020-12-05 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$100,000
+10,000,000 vol
$0.01 each
Filed 2020-12-06 11:23
Tx date 2020-12-03 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-100,000
-10,000,000 vol
$0.01 each 		8,272,500
Filed 2020-12-04 23:40
Tx date 2020-12-04 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-1,830
-183,000 vol
$0.01 each 		41,568,000
Filed 2020-12-04 23:39
Tx date 2020-12-03 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-10,000
-1,000,000 vol
$0.01 each 		41,751,000
Filed 2020-12-04 23:38
Tx date 2020-12-02 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-50,000
-5,000,000 vol
$0.01 each 		42,751,000
Filed 2020-12-04 23:37
Tx date 2020-12-01 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$3,890
+389,000 vol
$0.01 each 		47,751,000
Filed 2020-11-25 15:54
Tx date 2020-11-25 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately
+10,000,000 vol 		10,000,000
Filed 2020-11-25 15:50
Tx date 2020-11-25 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately
+100,000,000 vol
Filed 2020-11-25 15:48
Tx date 2020-03-19 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2020-11-25 15:47
Tx date 2020-11-25 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$100,000
+10,000,000 vol
$0.01 each 		10,000,000
Filed 2020-11-25 15:46
Tx date 2020-03-19 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-07-19 11:57
Tx date 2020-05-26 		$HEM
Hemostemix Inc. 		Wood, Blake
3 - 10% Security Holder of Issuer
Holder: Wood Capital Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-78,550
-7,855,000 vol
$0.01 each 		70,145,000
Filed 2020-07-19 11:55
Tx date 2020-05-21 		$HEM
Hemostemix Inc. 		Wood, Blake
3 - 10% Security Holder of Issuer
Holder: Wood Capital Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-100,000
-10,000,000 vol
$0.01 each 		78,000,000
Filed 2020-07-19 11:54
Tx date 2020-05-25 		$HEM
Hemostemix Inc. 		Wood, Blake
3 - 10% Security Holder of Issuer
Holder: Wood Capital Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-100,000
-10,000,000 vol
$0.01 each
Filed 2020-07-19 11:43
Tx date 2017-01-13 		$HEM
Hemostemix Inc. 		Wood, Blake
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-07-19 11:39
Tx date 2017-01-13 		$HEM
Hemostemix Inc. 		Wood, Blake
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-05-28 21:55
Tx date 2020-05-28 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption
+13,472,500 vol 		17,072,500
Filed 2020-05-28 21:50
Tx date 2020-05-28 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$1,815,082,562,500
+13,472,500 vol
$134,725 each 		18,272,500
Filed 2020-04-21 11:54
Tx date 2020-04-08 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Tanya Swanberg (Indirect Ownership)
Warrants
00 - Opening Balance-Initial SEDI Report 		1,900,000
Filed 2020-04-21 11:53
Tx date 2020-04-08 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Landsman Properties Ltd, (Indirect Ownership)
Warrants
00 - Opening Balance-Initial SEDI Report 		15,000,000
Filed 2020-04-21 11:52
Tx date 2020-04-08 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: LTUS Ltd. (Indirect Ownership)
Warrants
00 - Opening Balance-Initial SEDI Report 		12,500,000
Filed 2020-04-21 11:52
Tx date 2020-04-08 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Loran and Tanya Swanberg JT (Indirect Ownership)
Warrants
00 - Opening Balance-Initial SEDI Report 		12,500,000
Filed 2020-04-21 11:50
Tx date 2020-04-08 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Tanya Swanberg (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report 		1,900,000
Filed 2020-04-21 11:48
Tx date 2020-04-08 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Landsman Properties Ltd, (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report 		15,300,000
Filed 2020-04-21 11:45
Tx date 2020-04-08 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: LTUS Ltd. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report 		14,500,000
Filed 2020-04-21 11:44
Tx date 2020-04-08 		$HEM
Hemostemix Inc. 		Swanberg, Loran
4 - Director of Issuer
Holder: Loran and Tanya Swanberg JT (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report 		12,800,000
Filed 2020-04-20 23:15
Tx date 2020-04-17 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-49,488
-3,093,000 vol
$0.016 each 		47,362,000
Filed 2020-04-09 22:41
Tx date 2020-03-19 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: Summerhill Inv Corp (Control or Direction)
Warrants
00 - Opening Balance-Initial SEDI Report 		3,000,000
Filed 2020-04-09 22:40
Tx date 2020-03-19 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Warrants
00 - Opening Balance-Initial SEDI Report 		47,000,000
Filed 2020-03-20 02:00
Tx date 2020-03-19 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: Summerhill Inv Corp (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report 		3,000,000
Filed 2020-03-20 01:59
Tx date 2020-03-19 		$HEM
Hemostemix Inc. 		Lacey, Peter Alan
4 - Director of Issuer
Holder: RRSP - Peter Lacey (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report 		50,455,000
Filed 2020-03-10 12:29
Tx date 2019-11-26 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report 		3,600,000
Filed 2020-03-10 12:25
Tx date 2020-03-05 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$129,600,000,000
+3,600,000 vol
$36,000 each 		4,800,000
Filed 2020-03-10 12:22
Tx date 2019-11-26 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Units 1 common share plus 1 common share purchase warrant
00 - Opening Balance-Initial SEDI Report
Filed 2020-03-10 12:19
Tx date 2019-11-26 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Units 1 common share plus 1 common share purchase warrant
00 - Opening Balance-Initial SEDI Report
Filed 2020-03-10 11:50
Tx date 2020-03-05 		$HEM
Hemostemix Inc. 		Hershman, Ronnie Allen Hershman
4 - Director of Issuer
Holder: Hershman Holdings, LLC (Control or Direction)
Warrants
53 - Grant of warrants
+10,001,254 vol 		10,001,254
Filed 2020-03-10 11:49
Tx date 2020-02-10 		$HEM
Hemostemix Inc. 		Hershman, Ronnie Allen Hershman
4 - Director of Issuer
Holder: Hershman Holdings, LLC (Control or Direction)
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2020-03-10 11:47
Tx date 2020-03-05 		$HEM
Hemostemix Inc. 		Hershman, Ronnie Allen Hershman
4 - Director of Issuer
Holder: Hershman Holdings, LLC (Control or Direction)
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$100,012
+10,001,254 vol
$0.01 each 		11,325,145
Filed 2020-03-09 17:06
Tx date 2020-03-05 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$50,000
+5,000,000 vol
$0.01 each 		5,300,000
Filed 2020-03-09 17:00
Tx date 2020-03-05 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Holder: DOUBLE CHECK CONSULTING INC. (Control or Direction)
Warrants
53 - Grant of warrants
+2,645,600 vol 		2,676,717
Filed 2020-03-09 16:59
Tx date 2020-03-05 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Holder: DOUBLE CHECK CONSULTING INC. (Indirect Ownership)
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$26,456
+2,645,600 vol
$0.01 each 		2,801,183
Filed 2020-03-09 16:58
Tx date 2020-03-05 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Holder: ZENITH APPRAISAL AND LAND CONSULTING LTD. (Indirect Ownership)
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$99,254
+9,925,466 vol
$0.01 each 		12,592,316
Filed 2020-03-09 16:57
Tx date 2020-03-05 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Holder: ZENITH APPRAISAL AND LAND CONSULTING LTD. (Control or Direction)
Warrants
53 - Grant of warrants
+9,925,466 vol 		10,925,466
Filed 2020-03-09 16:54
Tx date 2020-03-05 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Direct Ownership
Warrants
53 - Grant of warrants
+5,000,000 vol 		5,080,000
Filed 2020-03-09 16:48
Tx date 2020-03-05 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$50,000
+5,000,000 vol
$0.01 each 		5,300,000
Filed 2020-03-09 16:48
Tx date 2020-03-05 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$50,000
+5,000,000 vol
$0.01 each
Filed 2020-02-21 13:34
Tx date 2020-02-10 		$HEM
Hemostemix Inc. 		Hershman, Ronnie Allen Hershman
4 - Director of Issuer
Holder: Hershman Holdings, LLC (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report 		1,323,891
Filed 2019-12-09 19:19
Tx date 2019-12-04 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$5,000
+500,000 vol
$0.01 each 		1,200,000
Filed 2019-12-03 17:12
Tx date 2019-11-26 		$HEM
Hemostemix Inc. 		Smeenk, Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		700,000
Filed 2019-04-09 11:41
Tx date 2019-03-29 		$HEM
Hemostemix Inc. 		JACOBS, ALAN
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$84,000
+1,050,000 vol
$0.08 each 		2,250,000
Filed 2019-04-09 11:36
Tx date 2019-03-29 		$HEM
Hemostemix Inc. 		JACOBS, ALAN
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		1,200,000
Filed 2019-01-02
Tx date 2019-01-02 		$HEM
Hemostemix Inc. 		Jain, Ravi
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-7,980
-140,000 vol
$0.057 each 		438,900
Filed 2019-01-02
Tx date 2019-01-02 		$HEM
Hemostemix Inc. 		Jain, Ravi
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-3,180
-50,000 vol
$0.0636 each 		388,900
Filed 2018-12-31
Tx date 2018-12-31 		$HEM
Hemostemix Inc. 		Jain, Ravi
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-3,710
-70,000 vol
$0.053 each 		578,900
Filed 2018-12-31
Tx date 2018-12-31 		$HEM
Hemostemix Inc. 		Jain, Ravi
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-3,745
-70,000 vol
$0.0535 each 		648,900
Filed 2018-12-24
Tx date 2018-12-24 		$HEM
Hemostemix Inc. 		Jain, Ravi
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-732.00
-120,000 vol
$0.0061 each 		718,900
Filed 2018-12-21
Tx date 2018-12-21 		$HEM
Hemostemix Inc. 		Jain, Ravi
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-26,230
-430,000 vol
$0.061 each 		838,900
Filed 2018-08-14
Tx date 2018-04-26 		$HEM
Hemostemix Inc. 		Jain, Ravi
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$125,000
+1,250,000 vol
$0.10 each 		1,250,000
Filed 2018-08-14
Tx date 2017-11-30 		$HEM
Hemostemix Inc. 		Jain, Ravi
5 - Senior Officer of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report 		634,450
Filed 2018-08-14
Tx date 2017-11-30 		$HEM
Hemostemix Inc. 		Jain, Ravi
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		1,268,900
Filed 2018-08-14
Tx date 2017-11-30 		$HEM
Hemostemix Inc. 		Jain, Ravi
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-07-31
Tx date 2017-01-19 		$HEM
Hemostemix Inc. 		Friesen, Donald Edelbert
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-07-31
Tx date 2018-04-26 		$HEM
Hemostemix Inc. 		Friesen, Donald Edelbert
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$50,000
+500,000 vol
$0.10 each 		500,000
Filed 2018-07-31
Tx date 2018-04-26 		$HEM
Hemostemix Inc. 		Friesen, Donald Edelbert
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$20,000
+200,000 vol
$0.10 each
Filed 2018-05-25
Tx date 2018-05-24 		$HEM
Hemostemix Inc. 		Wood, Jed Morgan
3 - 10% Security Holder of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Alison Wood (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$70.00
+1,000 vol
$0.07 each 		281,000
Filed 2018-05-25
Tx date 2018-05-22 		$HEM
Hemostemix Inc. 		Wood, Jed Morgan
3 - 10% Security Holder of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Alison Wood (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$7,000
+100,000 vol
$0.07 each 		280,000
Filed 2018-05-25
Tx date 2018-05-22 		$HEM
Hemostemix Inc. 		Wood, Jed Morgan
3 - 10% Security Holder of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Alison Wood (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$12,600
+180,000 vol
$0.07 each 		180,000
Filed 2018-05-25
Tx date 2016-12-21 		$HEM
Hemostemix Inc. 		Wood, Jed Morgan
3 - 10% Security Holder of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Alison Wood (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-05-09
Tx date 2018-04-27 		$HEM
Hemostemix Inc. 		Jenkins, Angus Herman
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+600,000 vol 		600,000
Filed 2018-05-09
Tx date 2016-08-11 		$HEM
Hemostemix Inc. 		Jenkins, Angus Herman
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-05-03
Tx date 2018-04-30 		$HEM
Hemostemix Inc. 		Gulka, Kristin
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		750,000
Filed 2018-05-01
Tx date 2018-04-26 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$50,000
+500,000 vol
$0.10 each 		535,000
Filed 2017-12-28
Tx date 2017-12-27 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Holder: ZENITH APPRAISAL AND LAND CONSULTING LTD. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$1,520
+19,000 vol
$0.08 each 		2,666,850
Filed 2017-12-23
Tx date 2017-12-21 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Holder: ZENITH APPRAISAL AND LAND CONSULTING LTD. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$480.00
+6,000 vol
$0.08 each 		2,647,850
Filed 2017-12-17
Tx date 2017-12-14 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Holder: ZENITH APPRAISAL AND LAND CONSULTING LTD. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$2,000
+25,000 vol
$0.08 each 		2,641,850
Filed 2017-10-20
Tx date 2016-12-21 		$HEM
Hemostemix Inc. 		MAKOFKA, KYLE
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-10-20
Tx date 2016-12-21 		$HEM
Hemostemix Inc. 		Wood, Jed Morgan
3 - 10% Security Holder of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Drive Capital Corp (Indirect Ownership)
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-10-20
Tx date 2017-09-15 		$HEM
Hemostemix Inc. 		Wood, Jed Morgan
3 - 10% Security Holder of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Drive Capital Corp (Indirect Ownership)
Options
50 - Grant of options 		$296,674
+5,933,494 vol
$0.05 each 		5,933,494
Filed 2017-10-20
Tx date 2017-09-15 		$HEM
Hemostemix Inc. 		MAKOFKA, KYLE
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$741,686
+14,833,736 vol
$0.05 each 		14,833,736
Filed 2017-09-21
Tx date 2017-09-15 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Holder: ZENITH APPRAISAL AND LAND CONSULTING LTD. (Control or Direction)
Common Shares
36 - Conversion or exchange 		$100,000
+2,000,000 vol
$0.05 each 		2,616,850
Filed 2017-09-21
Tx date 2017-09-15 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Direct Ownership
Common Shares
36 - Conversion or exchange 		$8,000
+160,000 vol
$0.05 each 		300,000
Filed 2017-09-21
Tx date 2017-01-13 		$HEM
Hemostemix Inc. 		Wood, Blake
3 - 10% Security Holder of Issuer
Holder: Wood Capital Ltd. (Control or Direction)
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2017-09-21
Tx date 2014-11-10 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Holder: ZENITH APPRAISAL AND LAND CONSULTING LTD. (Control or Direction)
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2017-09-21
Tx date 2017-09-15 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Holder: ZENITH APPRAISAL AND LAND CONSULTING LTD. (Control or Direction)
Warrants
36 - Conversion or exchange
+1,000,000 vol 		1,000,000
Filed 2017-09-21
Tx date 2014-11-10 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2017-09-21
Tx date 2017-09-15 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Direct Ownership
Warrants
36 - Conversion or exchange
+80,000 vol 		80,000
Filed 2017-09-21
Tx date 2014-11-10 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Holder: DOUBLE CHECK CONSULTING INC. (Indirect Ownership)
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2017-09-21
Tx date 2017-09-15 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Holder: DOUBLE CHECK CONSULTING INC. (Indirect Ownership)
Warrants
36 - Conversion or exchange
+31,117 vol 		31,117
Filed 2017-09-21
Tx date 2017-09-15 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Holder: DOUBLE CHECK CONSULTING INC. (Indirect Ownership)
Common Shares
36 - Conversion or exchange 		$3,111
+62,233 vol
$0.05 each 		155,583
Filed 2017-09-21
Tx date 2017-09-15 		$HEM
Hemostemix Inc. 		Wood, Blake
3 - 10% Security Holder of Issuer
Holder: Wood Capital Ltd. (Control or Direction)
Convertible Debentures
36 - Conversion or exchange 		$
-$4,400,000 vol
$0.05 each 		$0
Filed 2017-09-21
Tx date 2017-09-15 		$HEM
Hemostemix Inc. 		Wood, Blake
3 - 10% Security Holder of Issuer
Holder: Wood Capital Ltd. (Control or Direction)
Convertible Debentures
16 - Acquisition or disposition under a prospectus exemption 		$
+$4,400,000 vol
$0.05 each 		$4,400,000
Filed 2017-09-21
Tx date 2017-09-15 		$HEM
Hemostemix Inc. 		Wood, Blake
3 - 10% Security Holder of Issuer
Holder: Wood Capital Ltd. (Control or Direction)
Convertible Debentures
36 - Conversion or exchange
-$1,000,000 vol 		$0
Filed 2017-09-21
Tx date 2017-01-13 		$HEM
Hemostemix Inc. 		Wood, Blake
3 - 10% Security Holder of Issuer
Holder: Wood Capital Ltd. (Control or Direction)
Convertible Debentures
00 - Opening Balance-Initial SEDI Report 		$1,000,000
Filed 2017-09-21
Tx date 2017-01-13 		$HEM
Hemostemix Inc. 		Wood, Blake
3 - 10% Security Holder of Issuer
Holder: Wood Capital Ltd. (Control or Direction)
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
Filed 2017-09-21
Tx date 2017-01-13 		$HEM
Hemostemix Inc. 		Wood, Blake
3 - 10% Security Holder of Issuer
Holder: Wood Capital Ltd. (Control or Direction)
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
Filed 2017-09-21
Tx date 2017-01-13 		$HEM
Hemostemix Inc. 		Wood, Blake
3 - 10% Security Holder of Issuer
Holder: Wood Capital Ltd. (Control or Direction)
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
Filed 2017-09-21
Tx date 2017-09-15 		$HEM
Hemostemix Inc. 		Wood, Blake
3 - 10% Security Holder of Issuer
Holder: Wood Capital Ltd. (Control or Direction)
Common Shares
36 - Conversion or exchange 		$4,400,000
+88,000,000 vol
$0.05 each 		88,000,000
Filed 2017-09-21
Tx date 2017-01-13 		$HEM
Hemostemix Inc. 		Wood, Blake
3 - 10% Security Holder of Issuer
Holder: Wood Capital Ltd. (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-09-21
Tx date 2017-09-15 		$HEM
Hemostemix Inc. 		Wood, Blake
3 - 10% Security Holder of Issuer
Holder: Wood Capital Ltd. (Control or Direction)
Warrants
36 - Conversion or exchange
+44,000,000 vol 		44,000,000
Filed 2017-09-13
Tx date 2016-12-21 		$HEM
Hemostemix Inc. 		MAKOFKA, KYLE
5 - Senior Officer of Issuer
Direct Ownership
Subscription Rights Subscription Receipts
00 - Opening Balance-Initial SEDI Report
Filed 2017-09-13
Tx date 2017-08-25 		$HEM
Hemostemix Inc. 		MAKOFKA, KYLE
5 - Senior Officer of Issuer
Direct Ownership
Subscription Rights Subscription Receipts
16 - Acquisition or disposition under a prospectus exemption
+4,000,000 vol 		4,000,000
Filed 2017-08-31
Tx date 2016-12-21 		$HEM
Hemostemix Inc. 		Wood, Jed Morgan
3 - 10% Security Holder of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Rights
00 - Opening Balance-Initial SEDI Report
Filed 2017-08-31
Tx date 2017-07-21 		$HEM
Hemostemix Inc. 		Wood, Jed Morgan
3 - 10% Security Holder of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Rights
56 - Grant of rights
+712,500 vol 		712,500
Filed 2017-08-31
Tx date 2017-08-11 		$HEM
Hemostemix Inc. 		Wood, Jed Morgan
3 - 10% Security Holder of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Rights
58 - Expiration of rights
-712,500 vol 		0
Filed 2017-08-30
Tx date 2017-08-25 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Holder: Double Check Consulting Inc. (Indirect Ownership)
Common Shares
57 - Exercise of rights 		$3,111
+62,233 vol
$0.05 each 		155,583
Filed 2017-08-30
Tx date 2017-08-25 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Holder: Zenith Aprraisal and Land Consulting Ltd (Indirect Ownership)
Subscription Rights Subscription Receipts
56 - Grant of rights
+2,000,000 vol 		2,000,000
Filed 2017-08-30
Tx date 2017-01-19 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Holder: Zenith Aprraisal and Land Consulting Ltd (Indirect Ownership)
Subscription Rights Subscription Receipts
00 - Opening Balance-Initial SEDI Report
Filed 2017-08-30
Tx date 2017-08-25 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Direct Ownership
Subscription Rights Subscription Receipts
56 - Grant of rights
+160,000 vol 		160,000
Filed 2017-08-30
Tx date 2017-01-19 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Direct Ownership
Subscription Rights Subscription Receipts
00 - Opening Balance-Initial SEDI Report
Filed 2017-08-30
Tx date 2017-08-25 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Holder: Zenith Aprraisal and Land Consulting Ltd (Indirect Ownership)
Rights
57 - Exercise of rights
+2,000,000 vol 		2,000,000
Filed 2017-08-30
Tx date 2017-01-19 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Holder: Zenith Aprraisal and Land Consulting Ltd (Indirect Ownership)
Rights
00 - Opening Balance-Initial SEDI Report
Filed 2017-08-30
Tx date 2017-08-25 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Holder: Double Check Consulting Inc. (Indirect Ownership)
Rights
57 - Exercise of rights
+62,233 vol 		62,233
Filed 2017-08-30
Tx date 2017-01-19 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Holder: Double Check Consulting Inc. (Indirect Ownership)
Rights
00 - Opening Balance-Initial SEDI Report
Filed 2017-08-30
Tx date 2017-08-25 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Direct Ownership
Rights
57 - Exercise of rights
+160,000 vol 		160,000
Filed 2017-08-30
Tx date 2017-01-19 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Direct Ownership
Rights
00 - Opening Balance-Initial SEDI Report
Filed 2017-08-30
Tx date 2017-08-25 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Holder: Zenith Aprraisal and Land Consulting Ltd (Indirect Ownership)
Common Shares
57 - Exercise of rights 		$100,000
+2,000,000 vol
$0.05 each 		2,616,850
Filed 2017-08-30
Tx date 2017-08-25 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Direct Ownership
Common Shares
56 - Grant of rights 		$8,000
+160,000 vol
$0.05 each 		300,000
Filed 2017-08-30
Tx date 2017-08-25 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Holder: DOUBLE CHECK CONSULTING INC. (Indirect Ownership)
Subscription Rights Subscription Receipts
56 - Grant of rights
+62,233 vol 		62,233
Filed 2017-08-30
Tx date 2014-11-10 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Holder: DOUBLE CHECK CONSULTING INC. (Indirect Ownership)
Subscription Rights Subscription Receipts
00 - Opening Balance-Initial SEDI Report
Filed 2017-07-26
Tx date 2017-07-13 		$HEM
Hemostemix Inc. 		Redekop, Victor
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-4,830
-69,000 vol
$0.07 each 		8,199,073
Filed 2017-07-26
Tx date 2017-07-17 		$HEM
Hemostemix Inc. 		Redekop, Victor
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-16,170
-231,000 vol
$0.07 each 		7,968,073
Filed 2017-07-12
Tx date 2017-06-30 		$HEM
Hemostemix Inc. 		Redekop, Victor
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-880.00
-11,000 vol
$0.08 each 		8,268,073
Filed 2017-02-23
Tx date 2017-01-13 		$HEM
Hemostemix Inc. 		Wood, Jed Morgan
3 - 10% Security Holder of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Drive Capital Corp (Control or Direction)
Warrants
11 - Acquisition or disposition carried out privately 		$500,000
+3,125,000 vol
$0.16 each
Filed 2017-02-23
Tx date 2017-01-13 		$HEM
Hemostemix Inc. 		Wood, Jed Morgan
3 - 10% Security Holder of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Drive Capital Corp (Control or Direction)
Warrants
11 - Acquisition or disposition carried out privately 		$500,000
+3,125,000 vol
$0.16 each
Filed 2017-02-23
Tx date 2017-01-13 		$HEM
Hemostemix Inc. 		Wood, Jed Morgan
3 - 10% Security Holder of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Drive Capital Corp (Control or Direction)
Common Shares
11 - Acquisition or disposition carried out privately 		$1,000,000
+6,250,000 vol
$0.16 each
Filed 2017-02-23
Tx date 2017-01-13 		$HEM
Hemostemix Inc. 		Wood, Jed Morgan
3 - 10% Security Holder of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Drive Capital Corp (Control or Direction)
Common Shares
11 - Acquisition or disposition carried out privately 		$1,000,000
+6,250,000 vol
$0.16 each
Filed 2017-02-23
Tx date 2016-12-21 		$HEM
Hemostemix Inc. 		Wood, Jed Morgan
3 - 10% Security Holder of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Drive Capital Corp (Control or Direction)
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2017-02-23
Tx date 2016-12-21 		$HEM
Hemostemix Inc. 		Wood, Jed Morgan
3 - 10% Security Holder of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Drive Capital Corp (Control or Direction)
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2017-02-23
Tx date 2017-01-13 		$HEM
Hemostemix Inc. 		Wood, Jed Morgan
3 - 10% Security Holder of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Drive Capital Corp (Control or Direction)
Warrants
11 - Acquisition or disposition carried out privately 		$1,000,000
+6,250,000 vol
$0.16 each
Filed 2017-02-13
Tx date 2017-02-13 		$HEM
Hemostemix Inc. 		Redekop, Victor
4 - Director of Issuer
Direct Ownership
Common Shares
47 - Acquisition or disposition by gift
-1,073,219 vol 		8,279,073
Filed 2017-02-03
Tx date 2017-01-13 		$HEM
Hemostemix Inc. 		Wood, Blake
3 - 10% Security Holder of Issuer
Holder: Wood Capital Ltd. (Control or Direction)
Convertible Debentures
00 - Opening Balance-Initial SEDI Report 		$1,000,000
Filed 2017-01-27
Tx date 2017-01-19 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		35,000
Filed 2017-01-27
Tx date 2017-01-19 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Holder: Zenith Aprraisal and Land Consulting Ltd (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report 		616,850
Filed 2017-01-27
Tx date 2017-01-19 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Holder: Double Check Consulting Inc. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report 		93,350
Filed 2017-01-27
Tx date 2017-01-19 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		140,000
Filed 2017-01-26
Tx date 2016-12-21 		$HEM
Hemostemix Inc. 		Wood, Jed Morgan
3 - 10% Security Holder of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Drive Capital Corp (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-01-26
Tx date 2017-01-13 		$HEM
Hemostemix Inc. 		Wood, Jed Morgan
3 - 10% Security Holder of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Drive Capital Corp (Control or Direction)
Common Shares
11 - Acquisition or disposition carried out privately 		$1,000,000
+6,250,000 vol
$0.16 each 		9,193,201
Filed 2017-01-26
Tx date 2017-01-12 		$HEM
Hemostemix Inc. 		Wood, Jed Morgan
3 - 10% Security Holder of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Drive Capital Corp (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-01-26
Tx date 2017-01-13 		$HEM
Hemostemix Inc. 		Wood, Jed Morgan
3 - 10% Security Holder of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Drive Capital Corp (Control or Direction)
Warrants
11 - Acquisition or disposition carried out privately 		$500,000
+3,125,000 vol
$0.16 each 		3,125,000
Filed 2017-01-26
Tx date 2017-01-13 		$HEM
Hemostemix Inc. 		Wood, Jed Morgan
3 - 10% Security Holder of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Drive Capital Corp (Control or Direction)
Warrants
11 - Acquisition or disposition carried out privately 		$1,000,000
+6,250,000 vol
$0.16 each
Filed 2017-01-26
Tx date 2016-12-21 		$HEM
Hemostemix Inc. 		Wood, Jed Morgan
3 - 10% Security Holder of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Drive Capital Corp (Control or Direction)
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2017-01-26
Tx date 2017-01-13 		$HEM
Hemostemix Inc. 		Wood, Jed Morgan
3 - 10% Security Holder of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Drive Capital Corp (Control or Direction)
Convertible Debentures
11 - Acquisition or disposition carried out privately 		$
-$1,000,000 vol
$0.16 each 		$0
Filed 2017-01-26
Tx date 2017-01-12 		$HEM
Hemostemix Inc. 		Wood, Jed Morgan
3 - 10% Security Holder of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Drive Capital Corp (Control or Direction)
Convertible Debentures
11 - Acquisition or disposition carried out privately 		$
+$1,000,000 vol
$0.16 each 		$1,000,000
Filed 2017-01-26
Tx date 2016-12-21 		$HEM
Hemostemix Inc. 		Wood, Jed Morgan
3 - 10% Security Holder of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Drive Capital Corp (Control or Direction)
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
Filed 2017-01-26
Tx date 2017-01-12 		$HEM
Hemostemix Inc. 		Wood, Jed Morgan
3 - 10% Security Holder of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: RRSP Account (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-01-26
Tx date 2016-12-21 		$HEM
Hemostemix Inc. 		Wood, Jed Morgan
3 - 10% Security Holder of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: RRSP Account (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report 		712,500
Filed 2017-01-26
Tx date 2016-12-21 		$HEM
Hemostemix Inc. 		Wood, Jed Morgan
3 - 10% Security Holder of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: RRSP Account (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-01-26
Tx date 2017-01-12 		$HEM
Hemostemix Inc. 		Wood, Jed Morgan
3 - 10% Security Holder of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: J.M. Wood Investments Ltd. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-01-26
Tx date 2017-01-05 		$HEM
Hemostemix Inc. 		Wood, Jed Morgan
3 - 10% Security Holder of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: J.M. Wood Investments Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-900.00
-5,000 vol
$0.18 each 		26,000
Filed 2017-01-26
Tx date 2017-01-04 		$HEM
Hemostemix Inc. 		Wood, Jed Morgan
3 - 10% Security Holder of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: J.M. Wood Investments Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-2,520
-14,000 vol
$0.18 each 		31,000
Filed 2017-01-26
Tx date 2016-12-21 		$HEM
Hemostemix Inc. 		Wood, Jed Morgan
3 - 10% Security Holder of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: J.M. Wood Investments Ltd. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report 		45,000
Filed 2017-01-26
Tx date 2016-12-21 		$HEM
Hemostemix Inc. 		Wood, Jed Morgan
3 - 10% Security Holder of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: J.M. Wood Investments Ltd. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-01-26
Tx date 2016-12-21 		$HEM
Hemostemix Inc. 		Wood, Jed Morgan
3 - 10% Security Holder of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Holder: Drive Capital Corp (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report 		2,943,201
Filed 2017-01-12
Tx date 2017-01-03 		$HEM
Hemostemix Inc. 		wunderlich, Lyle
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
36 - Conversion or exchange 		$180,000
+1,125,000 vol
$0.16 each 		2,982,327
Filed 2017-01-12
Tx date 2017-01-03 		$HEM
Hemostemix Inc. 		wunderlich, Lyle
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
36 - Conversion or exchange 		$-180,000
-1,125,000 vol
$0.16 each
Filed 2017-01-12
Tx date 2017-01-11 		$HEM
Hemostemix Inc. 		wunderlich, Lyle
3 - 10% Security Holder of Issuer
Direct Ownership
Convertible Debentures
11 - Acquisition or disposition carried out privately
-$1,000,000 vol 		$0
Filed 2017-01-05
Tx date 2017-01-03 		$HEM
Hemostemix Inc. 		wunderlich, Lyle
3 - 10% Security Holder of Issuer
Direct Ownership
Promissory Notes
36 - Conversion or exchange 		$
-$180,000 vol
$0.16 each 		$0
Filed 2017-01-05
Tx date 2017-01-03 		$HEM
Hemostemix Inc. 		wunderlich, Lyle
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
36 - Conversion or exchange 		$-180,000
-1,125,000 vol
$0.16 each 		732,327
Filed 2017-01-04
Tx date 2017-01-03 		$HEM
Hemostemix Inc. 		Baker, Charles William
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
36 - Conversion or exchange 		$114,000
+712,500 vol
$0.16 each 		9,760,587
Filed 2017-01-04
Tx date 2017-01-03 		$HEM
Hemostemix Inc. 		Baker, Charles William
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Promissory Notes
36 - Conversion or exchange 		$
-$114,000 vol
$0.16 each 		$0
Filed 2017-01-04
Tx date 2017-01-03 		$HEM
Hemostemix Inc. 		Redekop, Victor
4 - Director of Issuer
Direct Ownership
Common Shares
36 - Conversion or exchange 		$350,000
+2,187,500 vol
$0.16 each 		9,352,292
Filed 2017-01-04
Tx date 2017-01-03 		$HEM
Hemostemix Inc. 		Redekop, Victor
4 - Director of Issuer
Direct Ownership
Promissory Notes
36 - Conversion or exchange 		$
-$350,000 vol
$0.16 each 		$0
Filed 2016-10-28
Tx date 2016-09-02 		$HEM
Hemostemix Inc. 		wunderlich, Lyle
3 - 10% Security Holder of Issuer
Direct Ownership
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
Filed 2016-10-28
Tx date 2016-09-02 		$HEM
Hemostemix Inc. 		wunderlich, Lyle
3 - 10% Security Holder of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report 		77,500
Filed 2016-10-28
Tx date 2016-09-02 		$HEM
Hemostemix Inc. 		wunderlich, Lyle
3 - 10% Security Holder of Issuer
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption
+3,125,000 vol
Filed 2016-10-28
Tx date 2016-09-02 		$HEM
Hemostemix Inc. 		wunderlich, Lyle
3 - 10% Security Holder of Issuer
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption
+3,125,000 vol
Filed 2016-10-28
Tx date 2016-09-02 		$HEM
Hemostemix Inc. 		wunderlich, Lyle
3 - 10% Security Holder of Issuer
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption
+500,000 vol
Filed 2016-10-28
Tx date 2016-09-02 		$HEM
Hemostemix Inc. 		wunderlich, Lyle
3 - 10% Security Holder of Issuer
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption
+500,000 vol
Filed 2016-10-28
Tx date 2016-09-02 		$HEM
Hemostemix Inc. 		wunderlich, Lyle
3 - 10% Security Holder of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2016-10-28
Tx date 2016-09-02 		$HEM
Hemostemix Inc. 		wunderlich, Lyle
3 - 10% Security Holder of Issuer
Direct Ownership
Promissory Notes
16 - Acquisition or disposition under a prospectus exemption
+$180,000 vol 		$180,000
Filed 2016-10-28
Tx date 2016-09-02 		$HEM
Hemostemix Inc. 		wunderlich, Lyle
3 - 10% Security Holder of Issuer
Direct Ownership
Promissory Notes
00 - Opening Balance-Initial SEDI Report
Filed 2016-10-28
Tx date 2016-09-02 		$HEM
Hemostemix Inc. 		wunderlich, Lyle
3 - 10% Security Holder of Issuer
Direct Ownership
Convertible Debentures
16 - Acquisition or disposition under a prospectus exemption 		$
+$1,000,000 vol
$0.16 each 		$1,000,000
Filed 2016-10-28
Tx date 2016-09-02 		$HEM
Hemostemix Inc. 		wunderlich, Lyle
3 - 10% Security Holder of Issuer
Holder: TFSA (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report 		29,753
Filed 2016-10-28
Tx date 2016-09-02 		$HEM
Hemostemix Inc. 		wunderlich, Lyle
3 - 10% Security Holder of Issuer
Holder: 769644 AB Ltd. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report 		603,300
Filed 2016-10-28
Tx date 2016-09-02 		$HEM
Hemostemix Inc. 		wunderlich, Lyle
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-10-28
Tx date 2016-09-02 		$HEM
Hemostemix Inc. 		wunderlich, Lyle
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-10-28
Tx date 2016-09-02 		$HEM
Hemostemix Inc. 		wunderlich, Lyle
3 - 10% Security Holder of Issuer
Holder: Spouse (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report 		48,053
Filed 2016-10-28
Tx date 2016-09-02 		$HEM
Hemostemix Inc. 		wunderlich, Lyle
3 - 10% Security Holder of Issuer
Holder: Children (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report 		51,000
Filed 2016-10-28
Tx date 2016-09-02 		$HEM
Hemostemix Inc. 		wunderlich, Lyle
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		1,857,327
Filed 2016-10-28
Tx date 2016-09-02 		$HEM
Hemostemix Inc. 		wunderlich, Lyle
3 - 10% Security Holder of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2016-09-29
Tx date 2016-09-28 		$HEM
Hemostemix Inc. 		Baker, Charles William
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
47 - Acquisition or disposition by gift
-1,000,000 vol 		9,048,087
Filed 2016-09-12
Tx date 2014-11-10 		$HEM
Hemostemix Inc. 		Baker, Charles William
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Promissory Notes
00 - Opening Balance-Initial SEDI Report
Filed 2016-09-12
Tx date 2016-09-06 		$HEM
Hemostemix Inc. 		Baker, Charles William
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$66,000
+660,000 vol
$0.10 each 		10,048,087
Filed 2016-09-12
Tx date 2016-09-06 		$HEM
Hemostemix Inc. 		Baker, Charles William
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
-660,000 vol 		540,000
Filed 2016-09-12
Tx date 2016-09-02 		$HEM
Hemostemix Inc. 		Baker, Charles William
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Promissory Notes
16 - Acquisition or disposition under a prospectus exemption
+$114,000 vol 		$114,000
Filed 2016-09-12
Tx date 2014-11-10 		$HEM
Hemostemix Inc. 		Redekop, Victor
4 - Director of Issuer
Direct Ownership
Promissory Notes
00 - Opening Balance-Initial SEDI Report
Filed 2016-09-12
Tx date 2016-09-02 		$HEM
Hemostemix Inc. 		Redekop, Victor
4 - Director of Issuer
Direct Ownership
Promissory Notes
16 - Acquisition or disposition under a prospectus exemption
+$350,000 vol 		$350,000
Filed 2016-06-17
Tx date 2016-06-17 		$HEM
Hemostemix Inc. 		Burchardt, Elmar Reinhold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$23.00
+100 vol
$0.23 each 		100
Filed 2016-06-17
Tx date 2014-11-10 		$HEM
Hemostemix Inc. 		Burchardt, Elmar Reinhold
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2015-11-30
Tx date 2015-11-26 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Holder: ZENITH APPRAISAL AND LAND CONSULTING LTD. (Control or Direction)
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$32,532
+50,050 vol
$0.65 each
Filed 2015-11-30
Tx date 2015-11-26 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Holder: ZENITH APPRAISAL AND LAND CONSULTING LTD. (Control or Direction)
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$50,050
+77,000 vol
$0.65 each 		616,850
Filed 2015-11-09
Tx date 2015-11-05 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Holder: ZENITH APPRAISAL AND LAND CONSULTING LTD. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$3,000
+5,000 vol
$0.60 each 		539,850
Filed 2015-11-05
Tx date 2015-11-04 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Holder: ZENITH APPRAISAL AND LAND CONSULTING LTD. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$1,800
+3,000 vol
$0.60 each 		532,850
Filed 2015-11-05
Tx date 2015-11-04 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Holder: ZENITH APPRAISAL AND LAND CONSULTING LTD. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$1,200
+2,000 vol
$0.60 each 		534,850
Filed 2015-11-04
Tx date 2015-11-03 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Holder: ZENITH APPRAISAL AND LAND CONSULTING LTD. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$620.00
+1,000 vol
$0.62 each 		529,850
Filed 2015-11-04
Tx date 2015-11-03 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Holder: ZENITH APPRAISAL AND LAND CONSULTING LTD. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$305.00
+500 vol
$0.61 each 		528,850
Filed 2015-11-04
Tx date 2015-11-03 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Holder: ZENITH APPRAISAL AND LAND CONSULTING LTD. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$1,500
+2,500 vol
$0.60 each 		528,350
Filed 2015-08-10
Tx date 2015-08-10 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Holder: ZENITH APPRAISAL AND LAND CONSULTING LTD. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$8,100
+10,000 vol
$0.81 each 		515,850
Filed 2015-08-10
Tx date 2015-08-10 		$HEM
Hemostemix Inc. 		Wood, David Leonard
4 - Director of Issuer
Holder: ZENITH APPRAISAL AND LAND CONSULTING LTD. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$8,200
+10,000 vol
$0.82 each 		525,850
Filed 2015-06-17
Tx date 2015-06-12 		$HEM
Hemostemix Inc. 		Fulga, Valentin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$10,000
+100,000 vol
$0.10 each 		280,000
Filed 2015-06-17
Tx date 2015-06-12 		$HEM
Hemostemix Inc. 		Fulga, Valentin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-10,000
-100,000 vol
$0.10 each 		1,250,000
Filed 2015-05-29
Tx date 2015-05-25 		$HEM
Hemostemix Inc. 		Fulga, Valentin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-3,825
-4,500 vol
$0.85 each 		180,000
Filed 2015-05-09
Tx date 2015-05-05 		$HEM
Hemostemix Inc. 		Fulga, Valentin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-4,250
-5,000 vol
$0.85 each 		184,500
Filed 2015-05-05
Tx date 2015-05-01 		$HEM
Hemostemix Inc. 		Fulga, Valentin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-3,915
-4,500 vol
$0.87 each 		194,000
Filed 2015-05-05
Tx date 2015-05-01 		$HEM
Hemostemix Inc. 		Fulga, Valentin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-3,825
-4,500 vol
$0.85 each 		189,500
Filed 2015-05-04
Tx date 2015-04-30 		$HEM
Hemostemix Inc. 		Fulga, Valentin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-2,225
-2,500 vol
$0.89 each 		198,500
Filed 2015-05-02
Tx date 2015-04-29 		$HEM
Hemostemix Inc. 		Fulga, Valentin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-5,220
-6,000 vol
$0.87 each 		201,000